MedTrace Logo

Post Study Continuation of C7 for G1D

NCT02018302 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2019-04-18

No results posted yet for this study

Summary

This protocol provides ongoing access to triheptanoin for patients who did complete an initial pilot protocol, and provides the opportunity to collect long-term safety data from patients treated with triheptanoin.

Conditions

  • Glut1 Deficiency Syndrome
  • Glucose Transporter Type 1 Deficiency Syndrome

Interventions

DRUG

Triheptanoin

Sponsors & Collaborators

  • Juan Pascual

    lead OTHER

Principal Investigators

  • Juan M Pascual, MD, PhD · UT Southwestern Medical Center

Eligibility

Min Age
1 Month
Max Age
28 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02018302 on ClinicalTrials.gov